ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

ClinicalTrials.gov ID: NCT06914128

Public ClinicalTrials.gov record NCT06914128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 12:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of BAY 3713372, a Novel 2nd Generation PRMT5 Inhibitor, in Participants With MTAP-deleted Solid Tumors.

Study identification

NCT ID
NCT06914128
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Bayer
Industry
Enrollment
370 participants

Conditions and interventions

Interventions

  • BAY 3713372 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2025
Primary completion
Jun 16, 2029
Completion
Jun 16, 2029
Last update posted
Apr 16, 2026

2025 – 2029

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham Alabama 35233 Not yet recruiting
City of Hope - Duarte Cancer Center Duarte California 91010 Not yet recruiting
UCLA Health Bowyer Oncology Center Los Angeles California 90095 Not yet recruiting
UCSF Helen Diller Medical Center at Parnassus Heights - Neurology San Francisco California 94143 Not yet recruiting
Stanford University Medical Center - Neurology Stanford California 94305 Not yet recruiting
UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center Aurora Colorado 80045 Not yet recruiting
Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's Denver Colorado 80218 Recruiting
Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona Orlando Florida 32827 Recruiting
Massachusetts General Hospital - Neurology Boston Massachusetts 02114 Not yet recruiting
Dana-Farber Cancer Institute - Oncology Department Boston Massachusetts 02215 Not yet recruiting
START | Midwest Grand Rapids Michigan 49546 Recruiting
Icahn School of Medicine at Mount Sinai - Oncology New York New York 10029 Not yet recruiting
Memorial Sloan Kettering Cancer Center New York - Main Campus New York New York 10065 Not yet recruiting
SCRI Oncology Partners Nashville Tennessee 37203 Recruiting
NEXT Dallas - Oncology Department Irving Texas 75039 Recruiting
START | San Antonio San Antonio Texas 78229 Recruiting
Froedtert Hospital - Clinical Cancer Center Milwaukee Wisconsin 53226 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06914128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06914128 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →